JUAN CARLOS
TORRE ALONSO
Catedrático de Universidad
MANUEL RUBEN
QUEIRO SILVA
Profesor Asociado en CC. Salud - LOSU
Publicaciones en las que colabora con MANUEL RUBEN QUEIRO SILVA (28)
2021
-
Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study
European Journal of Clinical Nutrition, Vol. 75, Núm. 9, pp. 1368-1382
2020
-
Disease features associated with a low disease impact in patients with psoriatic arthritis: Results of a cross-sectional multicenter study
Arthritis Research and Therapy, Vol. 22, Núm. 1
2019
-
Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis
Annals of the Rheumatic Diseases, Vol. 78, Núm. 3, pp. 355-364
-
Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis 11 Medical and Health Sciences 1117 Public Health and Health Services 11 Medical and Health Sciences 1103 Clinical Sciences
Arthritis Research and Therapy, Vol. 21, Núm. 1
-
Very low disease activity, DAPSA remission, and impact of disease in a Spanish population with psoriatic arthritis
Journal of Rheumatology, Vol. 46, Núm. 7, pp. 710-715
2018
-
Patient-reported outcomes in european spondyloarthritis patients: A systematic review of the literature
Patient Preference and Adherence, Vol. 12, pp. 733-747
-
Recommendations of the Spanish Society of Rheumatology on treatment and use of systemic biological and non-biological therapies in psoriatic arthritis
Reumatologia Clinica, Vol. 14, Núm. 5, pp. 254-268
2017
-
Minimal disease activity and impact of disease in psoriatic arthritis: A Spanish cross-sectional multicenter study
Arthritis Research and Therapy, Vol. 19, Núm. 1
2016
-
Urine metabolome profiling of immune-mediated inflammatory diseases
BMC Medicine, Vol. 14, Núm. 1
2015
-
A deletion at adamts9-magi1 locus is associated with psoriatic arthritis risk
Annals of the Rheumatic Diseases, Vol. 74, Núm. 10, pp. 1875-1881
2014
-
PDE3A-SLCO1C1 locus is associated with response to anti-tumor necrosis factor therapy in psoriatic arthritis
Pharmacogenomics, Vol. 15, Núm. 14, pp. 1763-1769
-
Standards of care for patients with spondyloarthritis
Rheumatology International, Vol. 34, Núm. 2, pp. 165-170
2013
-
Diferente expresión clínica de los pacientes con espondilitis anquilosante según el sexo en función del tiempo de evolución. Datos de REGISPONSER
Reumatologia Clinica, Vol. 9, Núm. 4, pp. 221-225
2012
-
Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subphenotypes
Human Molecular Genetics, Vol. 21, Núm. 20, pp. 4549-4557
2011
-
Documento SER de consenso sobre el uso de terapias biológicas en la artritis psoriásica
Reumatologia Clinica, Vol. 7, Núm. 3, pp. 179-188
-
High-dose etanercept in ankylosing spondylitis: Results of a 12-week randomized, double blind, controlled multicentre study (LOADET study)
Rheumatology, Vol. 50, Núm. 10, pp. 1828-1837
2008
-
Registro Nacional de Pacientes con Espondiloartritis (REGISPONSER). Análisis descriptivo de los 2.367 pacientes españoles incluidos
Reumatologia Clinica Suplementos, Vol. 4, Núm. SUPPL. 4, pp. 48-55
2004
-
The effect of HLA-DR antigens on the susceptibility to, and clinical expression of psoriatic arthritis
Scandinavian Journal of Rheumatology, Vol. 33, Núm. 5, pp. 318-322
2003
-
A polyarticular onset predicts erosive and deforming disease in psoriatic arthritis
Annals of the Rheumatic Diseases, Vol. 62, Núm. 1, pp. 68-70
-
HLA antigens may influence the age of onset of psoriasis and psoriatic arthritis
Journal of Rheumatology, Vol. 30, Núm. 3, pp. 505-507